Medfinder
Back to blog

Updated: January 28, 2026

How to Help Your Patients Save Money on Eysuvis: A Provider's Guide to Savings Programs

Author

Peter Daggett

Peter Daggett

Healthcare provider reviewing medication cost savings chart

Eysuvis costs $529–$687 without assistance. This provider guide walks through every savings program available in 2026 so you can help patients afford their prescription.

Eysuvis is a valuable short-term therapy for dry eye flares, but its retail cash price of $529 to $687 per 8.3 mL bottle creates a significant prescription abandonment risk. When patients arrive at the pharmacy and encounter that price — even with insurance — many simply don't fill the prescription. This directly impacts patient outcomes and your treatment plans. This guide gives you a complete picture of available savings programs so you can proactively address cost at the point of prescribing.

The Prescription Abandonment Problem

High-cost brand-name specialty ophthalmic medications have significant prescription abandonment rates. For Eysuvis specifically, several factors compound the cost challenge:

No generic equivalent exists as of 2026 — there is no cheaper biosimilar option

Many plans place Eysuvis on Tier 3-4, resulting in higher patient copays even with coverage

Prior authorization requirements create delays that can lead patients to abandon the prescription

Patients prescribed Eysuvis for a short 2-week course may perceive the cost as disproportionate to a temporary treatment

Savings Program 1: Alcon Patient Access Program Copay Card

The Alcon Patient Access Program (APAP) is the most impactful savings vehicle for your commercially insured patients. Here are the key details:

Insured with Eysuvis on formulary: Copay as little as $30 per prescription

Insured without Eysuvis coverage: Pay as little as $79 per prescription

Eligibility requirement: Must have commercial (private) insurance. Medicare, Medicaid, and government-funded insurance programs are NOT eligible

How to activate: Register at alconpatientaccessprogram.com or by calling 844-373-0987. The card can be downloaded, printed, or saved to a phone. Maximum savings limits apply.

Expiration: December 31, 2026

Provider action: Consider keeping a QR code or handout for alconpatientaccessprogram.com in your exam room or on your Eysuvis patient education materials. The 60 seconds spent sharing this at the visit can prevent a prescription abandonment call three days later.

Savings Program 2: Alcon Cares Patient Assistance Program

For patients who are uninsured, underinsured, or experiencing financial hardship, Alcon Cares provides Eysuvis at no cost to eligible patients. This is a formal pharmaceutical patient assistance program (PAP):

Eligibility: US resident, limited or no private or public prescription coverage, meets income requirements

Application: Contact Alcon Cares at 800-222-8103 or visit myalcon.com/payment-assistance-programs

Note: All new enrollment is done electronically or by phone; application requires prescriber involvement in most cases

Your office's medical assistant or care coordinator can often help patients initiate the Alcon Cares application during or after the visit.

Savings Program 3: BlinkRx Home Delivery

Alcon's BlinkRx digital pharmacy delivers Eysuvis directly to patients' homes. Key benefits for providers:

Automatically processes insurance and applies eligible Alcon savings at checkout — patients don't need to manage copay cards manually

Typically has more reliable Eysuvis stock than local chain pharmacies

Reduces the "pharmacy stock gap" issue — patients don't need to call around to find it in stock

BlinkRx contact: 1-844-926-2480; available through myalcon.com

For Medicare and Medicaid Patients

Patients on Medicare or Medicaid are not eligible for the Alcon Patient Access Program copay card. For these patients:

Check their specific Part D plan formulary — some Medicare Advantage and Part D plans do cover Eysuvis. Cigna Medicare added Eysuvis as a preferred brand in 2022.

GoodRx and SingleCare coupons CAN be used by Medicare patients in cash-pay situations — these can reduce the price to approximately $479–$515 per bottle

For low-income Medicare patients who also have limited income, the Alcon Cares PAP may still apply if they lack Part D coverage or have inadequate coverage

Maximizing Prior Authorization Success to Protect Coverage

Getting PA approved is essential to accessing insurance benefits (and therefore copay card benefits). Your PA submission for Eysuvis should include:

Diagnosis with ICD-10 code (H04.123 bilateral, or appropriate laterality code for dry eye disease)

Documentation of flare frequency, severity (ODS scores or patient-reported symptoms), and functional impact

Prior therapy history: OTC artificial tears (type and duration), prior cyclosporine if applicable, and treatment outcomes

Clinical rationale for Eysuvis specifically: the only FDA-approved corticosteroid for dry eye disease, short-term use for flare management, and need for rapid onset (as demonstrated in clinical trials showing benefit as early as Day 4)

Embedding Savings Support Into Your Practice Workflow

A streamlined practice approach to Eysuvis access:

At the point of prescribing: Identify insurance type (commercial vs. Medicare/Medicaid vs. uninsured)

Commercial insurance: Hand patient the APAP information (alconpatientaccessprogram.com or call 844-373-0987). Initiate PA if required by their plan.

Medicare/Medicaid: Check Part D formulary; direct to GoodRx/SingleCare as cash-pay backup; assess Alcon Cares eligibility for low-income patients.

Uninsured: Assess Alcon Cares PAP eligibility; otherwise GoodRx/SingleCare for cash-pay (~$479–$515).

All patients: Mention medfinder.com for finding which pharmacy near them has Eysuvis in stock.

Reducing Callbacks With medfinder

One common source of callbacks after an Eysuvis prescription: "My pharmacy doesn't have it in stock." Recommending medfinder for providers at the point of prescribing empowers patients to find the nearest pharmacy with stock on their own. medfinder calls pharmacies, checks stock, and texts the patient the results — reducing callbacks to your office and speeding up the patient's access to medication.

Quick Reference: Eysuvis Savings by Patient Type (2026)

Commercially insured, Eysuvis covered: Alcon APAP copay card → as little as $30

Commercially insured, Eysuvis not covered: Alcon APAP card → as little as $79

Medicare/Medicaid, no coverage: GoodRx (~$514) or SingleCare (~$479)

Uninsured, meets income criteria: Alcon Cares PAP → free

Uninsured, above income threshold: SingleCare (~$479) or GoodRx (~$514); Alcon APAP uninsured rate ($79) if available

Frequently Asked Questions

The main programs are: (1) Alcon Patient Access Program — $30 for commercially insured patients with coverage, $79 without; (2) Alcon Cares PAP — free for eligible low-income/uninsured patients; (3) GoodRx — approximately $514 cash price; (4) SingleCare — approximately $479 cash price; (5) BlinkRx home delivery — auto-applies insurance and savings programs.

No. The Alcon Patient Access Program copay card is restricted to commercially insured patients. Medicare and Medicaid patients are not eligible. Medicare patients can use GoodRx or SingleCare coupons as cash-pay alternatives, or check if their Part D plan covers Eysuvis at an affordable tier.

For dry eye disease, use H04.123 (keratoconjunctivitis sicca, bilateral, not specified as Sjogren's) or the appropriate laterality code: H04.121 (right eye), H04.122 (left eye). If the patient has Sjogren's syndrome-related dry eye, M35.0 (Sjogren syndrome) is also relevant. Document flare severity, functional impact, and prior therapy failures to support the PA.

Recommend medfinder.com to your patients. medfinder calls pharmacies near the patient to check which ones have their medication in stock, then texts results to the patient. This is more reliable than patients calling around themselves, and it reduces callbacks to your office. It works for Eysuvis and other specialty eye drops.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards

Patients searching for Eysuvis also looked for:

36,651 have already found their meds with Medfinder.

Start your search today.

36K+
5-star ratingTrusted by 36,651 Happy Patients
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast turnaround time
Never call another pharmacy

Need this medication?